Ministers take observe: now’s the second to battle to maintain AstraZeneca’s itemizing in London | Nils Pratley

It was a chance for Sir Pascal Soriot, as chief government of AstraZeneca, the UK’s most interesting pharmaceutical agency, to kill the story stone useless if he wished. Does he wish to transfer the corporate’s inventory market itemizing to the US, as reported by the Instances a couple of weeks in the past? He declined to reply. Then he did one thing else: he turned his press convention after Tuesday’s half-year numbers right into a declaration of affection, kind of, for all issues American.